Patrick Albers
Papers
1
Total Citations
12
H-Index
1
About
Patrick Albers is a leading urologic oncologist whose research centers on optimizing surgical outcomes for kidney cancer patients. His most impactful work directly addresses a critical clinical debate: whether robotic-assisted partial nephrectomy (RAPN) offers tangible advantages over the traditional open approach (OPN) for complex tumors. As the principal investigator of the landmark OpeRa trial, a prospective, randomized, multicenter study, Albers provided high-level evidence on this question. The trial’s final results, published in 2025, rigorously compared 30-day postoperative complication rates between the two techniques in patients with intermediate/high-complexity kidney tumors. This work has already garnered significant attention, with 12 citations shortly after publication, underscoring its immediate impact on surgical practice. By generating Level 1 evidence in a field often dominated by retrospective data, Albers has helped clarify the role of robotics in nephron-sparing surgery. His contributions are vital for surgeons making evidence-based decisions, ultimately aiming to reduce patient morbidity while maintaining oncologic efficacy. Albers continues to shape the future of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1